Octopath AI
AI digital pathology tools for H&E and IHC tissue slides
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Octopath AI is a UCL spinout building AI tools that work alongside pathologists to analyse routine H&E and immunohistochemistry (IHC) tissue slides, with foundation models and products for cell detection, mitosis detection, immune scoring and biomarker scoring. It was founded by Dr Zhuoyan Shen, Dr Charles-Antoine Collins Fekete and Dr Esther Bär of UCL's Department of Medical Physics and Biomedical Engineering. On November 2, 2026 it launched with £1.5 million in seed investment led by TwinPath Ventures plus a matched £500,000 Innovate UK Growth Catalyst grant, and it is one of seven companies in the MHRA's AI Airlock Phase 2.
- Website
- octopath.ai
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Compass Platform — Browser slide viewer with AI overlays, exports and LIMS/Epic integration · Saas
- Kraken-1 — Foundation model for cell- and tissue-level analysis on H&E slides · Other
- Octopath Nemo — IHC foundation model scoring every cell for Ki67, PD-L1, HER2 and ER/PR · Other